|1||NCT02365831||Recruiting||Observation of Medical Treatments in MBC HER2-negative Patients||
||Other / Industry||
||1500||Female||18 Years and older (Adult, Senior)||NCT02365831||GIM13-AMBRA||AMBRA||May 2015||December 2016||December 2017||February 19, 2015||June 15, 2016||
|2||NCT00005970||Active, not recruiting||Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer||
||NIH / Other||
||3441||Female||18 Years and older (Adult, Senior)||NCT00005970||NCI-2012-01849
|May 19, 2000||November 15, 2009||January 27, 2003||August 22, 2017||
† Study has passed its completion date and status has not been verified in more than two years.